Cargando…
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
BACKGROUND: A phasic dysregulation of mitochondrial bioenergetics may operate in bipolar disorder, increased in mania and decreased in depression. We aimed to examine efficacy of two add-on treatments in bipolar depression: N-acetylcysteine (NAC) and NAC with a combination of nutraceutical agents th...
Autores principales: | Berk, Michael, Turner, Alyna, Malhi, Gin S., Ng, Chee, Cotton, Susan M., Dodd, Seetal, Samuni, Yuval, Tanious, Michelle, McAulay, Claire, Dowling, Nathan, Sarris, Jerome, Owen, Lauren, Waterdrinker, Astrid, Smith, Deidre, Dean, Olivia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346513/ https://www.ncbi.nlm.nih.gov/pubmed/30678686 http://dx.doi.org/10.1186/s12916-019-1257-1 |
Ejemplares similares
-
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019) -
Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022) -
Speaker 4: Michael Berk
por: M, Berk, et al.
Publicado: (2016) -
Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023) -
The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial
por: Russell, Samantha E., et al.
Publicado: (2023)